SCHEMBL23786

SCHEMBL23786

OB(O)c1ccc2n[nH]cc2c1

nearest known ligand 0.46

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 6/20 0.46
CA2 P00918 3/20 0.45
CA1 P00915 2/20 0.45
TTR P02766 4/20 0.41
LPL P06858 1/20 0.37
LIPG Q9Y5X9 1/20 0.37
IDO1 P14902 1/20 0.33
TDO2 P48775 1/20 0.33
ABL1 P00519 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18066769 0.84 ENPP2 (0.46) ENPP2CA2CA1TTRLPL
SCHEMBL19359062 0.75 ALDH1A1 (0.48) ENPP2TTR
SCHEMBL12653740 0.72 CYP1A2 (0.48)
SCHEMBL4773397 0.71 NOS1 (0.39)
SCHEMBL21404755 0.71 KDM4E (0.54) ENPP2CA2CA1TTR
SCHEMBL16523221 0.71 F7 (0.48)
SCHEMBL7582475 0.71 KDM4E (0.48)
SCHEMBL16523329 0.71 BACE1 (0.44) IDO1TDO2
SCHEMBL13415 0.71 BACE1 (0.44)
SCHEMBL16738830 0.71 CYP1A2 (0.57) ENPP2CA2CA1TTRLPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049746-A1 COMPOSITIONS COMPRISING WERNER SYNDROME HELICASE INHIBITORS AND METHODS OF USING THE SAME EIKON THERAPEUTICS, INC. (US) 2025-03-06 WO disclosed
EP-2609089-A1 SELECTIVE 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS Universität des Saarlandes (DE) 2013-07-03 EP disclosed
WO-2012025638-A1 SELECTIVE 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS Universität des Saarlandes (DE) 2012-03-01 WO disclosed